XOMA Royalty Corp
XOMA24.860USD
-0.060-0.24%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
306.03MMarket Cap
30.63P/E TTM
More Details of XOMA Royalty Corp Company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.
XOMA Royalty Corp Info
Ticker SymbolXOMA
Company nameXoma Royalty Corp
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Number of employees13
Security typeOrdinary Share
Fiscal year-endJun 06
Address2200 Powell Street
CityEMERYVILLE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94608
Phone15102047200
Websitehttps://xoma.com/
Ticker SymbolXOMA
IPO dateJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Company Executives of XOMA Royalty Corp
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Switzerland
6.72M
71.90%
United States
2.63M
28.10%
Asia Pacific
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BVF Partners L.P.
20.92%
Morgan Stanley Investment Management Inc. (US)
13.21%
Fidelity Management & Research Company LLC
8.37%
The Vanguard Group, Inc.
5.67%
BlackRock Institutional Trust Company, N.A.
4.39%
Other
47.44%
Shareholders
Shareholders
Proportion
BVF Partners L.P.
20.92%
Morgan Stanley Investment Management Inc. (US)
13.21%
Fidelity Management & Research Company LLC
8.37%
The Vanguard Group, Inc.
5.67%
BlackRock Institutional Trust Company, N.A.
4.39%
Other
47.44%
Shareholder Types
Shareholders
Proportion
Hedge Fund
25.22%
Investment Advisor
22.68%
Investment Advisor/Hedge Fund
19.61%
Individual Investor
1.79%
Research Firm
0.36%
Pension Fund
0.17%
Bank and Trust
0.08%
Insurance Company
0.03%
Other
30.06%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
133
8.37M
67.32%
--
2025Q4
153
8.45M
68.20%
+59.03K
2025Q3
138
8.25M
68.26%
+399.67K
2025Q2
147
7.87M
65.79%
+337.12K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BVF Partners L.P.
2.59M
20.92%
--
--
Sep 30, 2025
Morgan Stanley Investment Management Inc. (US)
1.64M
13.21%
+111.13K
+7.29%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.04M
8.37%
-1.76K
-0.17%
Sep 30, 2025
The Vanguard Group, Inc.
668.11K
5.4%
+29.30K
+4.59%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
544.18K
4.39%
+4.06K
+0.75%
Sep 30, 2025
Opaleye Management Inc.
255.09K
2.06%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
211.98K
1.71%
+8.38K
+4.11%
Sep 30, 2025
Woodline Partners LP
209.94K
1.7%
+29.71K
+16.49%
Sep 30, 2025
State Street Investment Management (US)
167.03K
1.35%
+13.55K
+8.83%
Sep 30, 2025
Stonepine Capital Management, LLC
115.46K
0.93%
-36.68K
-24.11%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Small Cap Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.06%
ProShares Hedge Replication ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
